Increasing αvβ3 selectivity of the anti-angiogenic drug cilengitide by N-methylation

Carlos Mas-Moruno, Johannes G. Beck, Lucas Doedens, Andreas O. Frank, Luciana Marinelli, Sandro Cosconati, Ettore Novellino, Horst Kessler

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Abstract

A subtle change: Structural changes upon amide bond methylation improve the selectivity of the anti-angiogenic drug Cilengitide, which after N-methylation at distinct positions discriminates between the closely related pro-angiogenic integrins αvβ3 and αvβ5 (see scheme).

Original languageEnglish
Pages (from-to)9496-9500
Number of pages5
JournalAngewandte Chemie International Edition in English
Volume50
Issue number40
DOIs
StatePublished - 26 Sep 2011

Keywords

  • N-methylation
  • conformational studies
  • cyclic peptides
  • integrin
  • receptor selectivity

Fingerprint

Dive into the research topics of 'Increasing αvβ3 selectivity of the anti-angiogenic drug cilengitide by N-methylation'. Together they form a unique fingerprint.

Cite this